![CD163 Protein](http://kactusbio.com/cdn/shop/articles/CDE163_blog_featured_image.jpg?v=1668673807&width=2800)
CD163 Protein
KACTUS offers human, mouse, and biotinylated CD163 protein. The hemoglobin (Hb) scavenger receptor CD163, is...
Nov 17, 2022
![TIDES Europe 2022](http://kactusbio.com/cdn/shop/articles/TIDES_Europe_2022_Blog_Featured_Image.jpg?v=1668019567&width=2800)
TIDES Europe 2022
KACTUS will be at TIDES Vienna on November 16-18th: Chat with us to see how we...
Nov 09, 2022
![October Products](http://kactusbio.com/cdn/shop/articles/Purple_image.jpg?v=1667222366&width=2800)
October Products
KACTUS has developed the following new products to facilitate the latest innovations in drug development....
Oct 28, 2022
![Targeting Axl-GAS6—a new option for tumor therapy](http://kactusbio.com/cdn/shop/articles/640_11.png?v=1663353110&width=2800)
Targeting Axl-GAS6—a new option for tumor therapy
Tumor drug resistance is a major problem limiting the clinical efficacy of therapeutic drugs. Recently,...
Sep 12, 2022
![Potential Immunotherapy Target TM4SF1](http://kactusbio.com/cdn/shop/articles/640_10.png?v=1663344832&width=2800)
Potential Immunotherapy Target TM4SF1
TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in...
Sep 05, 2022
![CDH17: A Safe CAR-T Target for Treatment of Solid Tumors](http://kactusbio.com/cdn/shop/articles/640_4.png?v=1660854724&width=2800)
CDH17: A Safe CAR-T Target for Treatment of Solid Tumors
Chimeric antigen receptor T cell (CAR-T) therapy has been successful in the field of hematological...
Jul 19, 2022
![GDF15-GFRAL breaks into the new drug track](http://kactusbio.com/cdn/shop/articles/GDF15_Blog.png?v=1689605496&width=2800)
GDF15-GFRAL breaks into the new drug track
A variety of metabolic diseases that plague today's society, such as obesity, diabetes, cancer, etc.,...
Jul 12, 2022